Results 41 to 50 of about 177,994 (348)

BRCA1 and Transcription [PDF]

open access: yesCancer Biology & Therapy, 2004
The BRCA1 tumor suppressor gene is expressed in all mammalian cells. Within these cells, the BRCA1 protein product interacts with several seemingly distinct nuclear complexes. Proteins within these complexes are potential targets for the E3-ubiquitin ligase activity associated with BRCA1:BARD1 complexes.
openaire   +2 more sources

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers

open access: yesMcGill Journal of Medicine, 2002
N ...
Patricia N. Tonin
doaj   +1 more source

Effect of BRCA1 R1325K mutation on proliferation and apoptosis of gallbladder cancer cells

open access: yesShanghai Jiaotong Daxue xuebao. Yixue ban, 2023
Objective·To investigate the effects of breast cancer susceptibility gene 1 (BRCA1) R1325K mutation [arginine (R) to lysine (K) mutation at amino acid 1325] on the proliferation and apoptosis of gallbladder cancer cell lines GBC-SD and NOZ.Methods·BRCA1 ...
YANG Jingxiao   +7 more
doaj   +1 more source

PALB2 self-interaction controls homologous recombination. [PDF]

open access: yes, 2012
PALB2 is essential for BRCA2 anchorage to nuclear structures and for homologous recombinational repair of DNA double-strand breaks. Here, we report that the N-terminal coiled-coil motif of PALB2 regulates its self-association and homologous recombination.
Buisson, Rémi, Masson, Jean-Yves
core   +1 more source

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer

open access: yesBreast Cancer: Targets and Therapy, 2023
Hikmat Abdel-Razeq,1,2 Lama Abujamous,3 Khansa Al-Azzam,1 Hala Abu-Fares,1 Hira Bani Hani,1 Mais Alkyam,1 Baha’ Sharaf,1 Shatha Elemian,1 Faris Tamimi,1 Fawzi Abuhijla,4 Sarah Edaily,1 Osama Salama,1 Hazem Abdulelah,1 Rand Daoud,1 Mohammad Abubaker,1 ...
Abdel-Razeq H   +15 more
doaj  

A systematic review on the association between ovarian and prostate cancer with BRCA1 and BRCA2 gene

open access: yesСибирский онкологический журнал, 2023
Background. BRCA1 and BRCA2 were discussed as the basis of inherited adenocarcinoma and breast and ovarian malignancy. Ovarian cancer is uncommon in women below 40 years of age, and prostate cancer mainly occurs in older men cause 90 % in those above ...
Sarpparajan Chitra Veena   +2 more
doaj   +1 more source

ОСОБЕННОСТИ ЭКСПРЕССИИ РЕЦЕПТОРОВ ЭСТРОГЕНОВ, ПРОГЕСТЕРОНА И АНДРОГЕНОВ ПРИ НАСЛЕДСТВЕННЫХ И СПОРАДИЧЕСКИХ ОВАРИАЛЬНЫХ КАРЦИНОМАХ

open access: yesŽurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2022
Введение. Овариальные карциномы – сложное гетерогенное заболевание с разнообразием клинико-морфологических форм. В большинстве случаев опухоли яичников экспрессируют эстрогеновые (РЭ), прогестероновые (РП) или андрогеновые (РА) рецепторы, но, в отличие ...
А. L. Savаnevich   +2 more
doaj   +1 more source

The impact of known breast cancer polygenes on critical illness insurance [PDF]

open access: yes, 2015
Genetic studies indicate that the inherited risk of breast cancer is mediated by the well-studied major genes BRCA1 and BRCA2, and a polygenic component, probably with many genes each making a small contribution. Recently, seven polygenes have been found
Adams, Craig   +2 more
core   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

BRCA1/2 associated cancer susceptibility: a clinical overview

open access: yesForum of Clinical Oncology, 2016
The most frequently identified genetic cause of breast cancer is the germline mutation of BRCA1 and 2 genes. The carriers of these mutations are at high risk for breast and ovarian cancers and increased risk for pancreatic and prostate cancers.
Lypas Georgios
doaj   +1 more source

Home - About - Disclaimer - Privacy